GRD Biotechnology Acquisition Ltd

GRD Biotechnology Acquisition Ltd, trading under the ticker CGRD, is a blank-check special purpose acquisition company that filed its S-1 registration statement with the SEC on July 26, 2023, initiating the IPO process with a stated focus on the biotechnology and life sciences sector. The company was established to identify and complete a business combination with a private target operating in biotech, pharmaceutical development, or adjacent healthcare industries. The filing represents one of several sector-specific SPAC vehicles that entered the registration pipeline during the 2023 calendar year. For complete data on CGRD, including sponsor profile, current deal status, and full filing history, sign up at SpacDesk.